Status:
COMPLETED
The Effects of the Intrapartum Care Model Given in Line With the Recommendations of the World Health Organization (WHO)
Lead Sponsor:
Selcuk University
Conditions:
Birth Outcome, Adverse
Breast Feeding
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The objective of this study was to examine the impact of the intrapartum care model that adheres to the guidelines set forth by the World Health Organization (WHO) on several key outcomes, including t...
Detailed Description
The study was a randomized controlled trial. The study was conducted with 128 primiparous pregnant women (intervention group n=64, control group n=64) admitted to the maternity unit of a training and ...
Eligibility Criteria
Inclusion
- Being 18 years of age or older,
- History of term pregnancy (38-42 weeks),
- Having a primiparous,
- Single, healthy, vertex positioned fetus,
- Having no complications that may cause dystocia in labor (such as contraction anomalies, birth object,
- Birth canal dystocia, dystocia related to the mother's psychology),
- Having a partner/husband,
- History of cervical dilatation of 5 cm or more,
- Having a healthy newborn,
- Being able to speak and understand Turkish.
Exclusion
- Being under 18 years of age,
- Having a diagnosed mental illness (depression, anxiety or other psychotic disorder, etc.),
- Having a chronic disease (hypertension, diabetes, etc.),
- Having maternal or fetal complications (oligohydramnios and polyhydramnios, placenta previa, pre-eclampsia, premature rupture of membranes, anomalies of presentation, intrauterine growth retardation, fetal anomaly, intrauterine death, fetal macrosomia, cord prolapse, etc.),
- Having any complication that prevents vaginal delivery (head-pelvis incompatibility, etc.),
- Having a history of elective cesarean section,
- Being pregnant with assisted reproductive techniques,
- Being multiparous,and having mastitis in the breast or having inverted nipples.
- The study also excluded women who had undergone a cesarean section due to any complication (e.g., cord entanglement, fetal distress),
- Who experienced complications related to the postpartum period (e.g., uterine atony, hemorrhage),
- And whose infant was admitted to the neonatal intensive care unit for any reason (e.g., respiratory distress).
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06551571
Start Date
January 1 2024
End Date
June 1 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seyhan Çankaya
Konya, Turkey (Türkiye), 42250